Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy

Annals of Neurology

Volumn 48, Issue 1, 2000, Pages 72-76

  Lodi, R ^a,b,d   Schapira, A H V ^b,c   Manners, D ^a   Styles, P ^a   Wood, N W ^c   Taylor, D J ^a   Warner, T T ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE; POLYGLUTAMINE;

ADULT; AEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; ENERGY METABOLISM; FEMALE; GENE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; MITOCHONDRION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0033914747     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I     Document Type: Article

References (26)

1. The Huntington's Disease Collaborative Group. The novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983
2. Hardy J, Gwinn-Hardy KG. Genetic classification of primary neurodegenerative disease. Science 1998;282:1075-1079
3. Davies SW, Beardsall K, Turmaine M, et al. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 1998;351:131-133
4. Gu M, Gash MT, Mann VM, et al. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996;39: 385-389
5. Browne SE, Bowling AC, MacGarvey U, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997;41:646-653
6. Mann VM, Cooper JM, Javoy-Agid F, et al. Mitochondrial function and parental sex effect in Huntington's disease. Lancet 1990;336:749 (Letter)
7. Tabrizi SJ, Cleeter MW, Xuereb J, et al. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 1999;45:25-32
8. Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington's disease. Ann Neurol 1998;43:397-400
9. 1H NMR spectroscopy. Neurology 1993; 43:2689-2695
10. 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology 1998;50:1357-1365
11. 1H MRS in the evaluation of Huntington's and Parkinsons diseases. Neurology 1988;50:1033-1040
12. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997;41:160-165
13. Nagafuchi S, Yanagisawa H, Sato K, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994;6:14-18
14. Warner TT, Williams LD, Walker RW, et al. A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four European families. Ann Neurol 1995;37:452-459
15. Ross CA, Becher MW, Colomer V, et al. Huntington's disease and dentatorubro-pallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol 1997;7:1003-1016
16. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements in 481 man and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97
17. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of P-31 NMR. Magn Reson Med 1984;1:307-315
18. Kemp GJ, Taylor DJ, Radda GK. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle. Nucl Magn Reson Biomed 1993;6:66-72
19. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 1955;217:409-427
20. Argov Z, Bank WJ, Maris J, et al. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987;37:257-262
21. Taylor DJ, Kemp GJ, Radda GK. Bioenergetics of skeletal muscle in mitochondrial myopathy. J Neurol Sci 1994;127:198-206
22. Lodi R, Taylor DJ, Tabrizi SJ, et al. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis. Brain 1998;121:1219-1226
23. 31P magnetic resonance spectroscopy study. Brain 1999; 122:121-130
24. Sawa A, Wiegand GW, Cooper J, et al. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 1999;5: 1194-1198
25. Sathasivam K, Hobbs C, Turmaine M, et al. Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 1999;8:813-822
26. Kuemmerle S, Gutekunst CA, Klein AM, et al. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol 1999;46:842-849